Diabetes mellitus is associated with shortened activated partial thromboplastin time and increased fibrinogen values
about
Plasma kallikrein-kinin system and diabetic retinopathyRole of plasma kallikrein in diabetes and metabolismAssociation of activated partial thromboplastin time and fibrinogen level in patients with type II diabetes mellitus.Proteomic analysis in type 2 diabetes patients before and after a very low calorie diet reveals potential disease state and intervention specific biomarkers.Utility of plasma fibrinogen in the differential diagnosis of thyrotoxicosis.Novel Dielectric Coagulometer Identifies Hypercoagulability in Patients with a High CHADS2 Score without Atrial Fibrillation.Estimating the contributions of rare and common genetic variations and clinical measures to a model trait: adiponectin.A review on the role of L-carnitine in the management of tamoxifen side effects in treated women with breast cancer.Evidence for a Hypercoagulable State in Women With Ovarian Endometriomas.The use of dielectric blood coagulometry in the evaluation of coagulability in patients with peripheral arterial disease.The effect of hyperglycaemia on haemostasis testing--a volunteer study.Evolutionarily derived networks to inform disease pathways.High risk of coagulopathy among Type-2 Diabetes Mellitus clients at a municipal hospital in Ghana.Mature coconut water exhibits antidiabetic and antithrombotic potential via L-arginine-nitric oxide pathway in alloxan induced diabetic rats.Influence of ABO type on global coagulation assay results: effect of coagulation factor VIII.Clinical Significance of Hemostatic Parameters in the Prediction for Type 2 Diabetes Mellitus and Diabetic Nephropathy.
P2860
Q26859982-502A968F-BF4D-4642-B085-736E68E5A633Q27016431-6A8788E0-8977-4972-A79E-33A11027BDEEQ34461796-EC0C8C29-7DDD-471D-892A-F14E5F17B1D3Q34557152-886B4953-141B-49FC-8C82-BFA81D806BF0Q35173816-6DCD956F-E5E6-4D2B-8642-63ABA443A904Q36044932-D784D6A7-A998-4D15-9FA6-31D617FBC4C9Q37078050-0734A55F-5096-47B4-ABDC-F5CACD15D0B9Q38171391-19E6D956-17BF-4B70-8516-447BA5D79138Q41377815-4FF96744-28AF-4898-AD2F-31CF2F9DE319Q41507499-699B3267-42D1-43E3-B826-BD494AE5BCB4Q47767292-24F189AA-8606-4C46-BF86-9DBAE342B526Q48298179-8FE42F39-1D62-4F30-85DB-109FD097931AQ53070194-1B5A8D26-9C80-4372-AC02-DA034E2CF2A7Q53439658-205F749F-697F-4D10-8509-F2C8171A7F18Q53662707-00CB9624-B56C-42DE-BB9A-13E901BD05C1Q55091608-E6DE90CC-EC75-431C-AAA7-DD0AE8597F6B
P2860
Diabetes mellitus is associated with shortened activated partial thromboplastin time and increased fibrinogen values
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Diabetes mellitus is associate ...... nd increased fibrinogen values
@ast
Diabetes mellitus is associate ...... nd increased fibrinogen values
@en
Diabetes mellitus is associate ...... nd increased fibrinogen values
@nl
type
label
Diabetes mellitus is associate ...... nd increased fibrinogen values
@ast
Diabetes mellitus is associate ...... nd increased fibrinogen values
@en
Diabetes mellitus is associate ...... nd increased fibrinogen values
@nl
prefLabel
Diabetes mellitus is associate ...... nd increased fibrinogen values
@ast
Diabetes mellitus is associate ...... nd increased fibrinogen values
@en
Diabetes mellitus is associate ...... nd increased fibrinogen values
@nl
P2093
P2860
P3181
P1433
P1476
Diabetes mellitus is associate ...... nd increased fibrinogen values
@en
P2093
Jianping Wu
Juanwen Zhang
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0016470
P407
P577
2011-01-28T00:00:00Z